[1]
R. Ravasio, F. Rigo, E. Lattuada, E. Concia, and M. Lanzafame, “Economic Evaluation of Nevirapine plus Raltegravir as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1 Infected Patients”, Grhta, vol. 3, no. 2, pp. 110–114, Jul. 2016.